1. Isolation and synthesis of falcitidin, a novel myxobacterial-derived acyltetrapeptide with activity against the malaria target falcipain-2.
- Author
-
Somanadhan B, Kotturi SR, Yan Leong C, Glover RP, Huang Y, Flotow H, Buss AD, Lear MJ, and Butler MS
- Subjects
- Antimalarials chemical synthesis, Antimalarials chemistry, Bacteroidetes chemistry, Bacteroidetes isolation & purification, Biological Assay, Drug Evaluation, Preclinical, Humans, Inhibitory Concentration 50, Magnetic Resonance Spectroscopy, Molecular Structure, Oligopeptides chemical synthesis, Oligopeptides chemistry, Protease Inhibitors chemical synthesis, Protease Inhibitors chemistry, Singapore, Soil Microbiology, Tandem Mass Spectrometry, Antimalarials isolation & purification, Antimalarials pharmacology, Cysteine Endopeptidases metabolism, Oligopeptides isolation & purification, Oligopeptides pharmacology, Protease Inhibitors isolation & purification, Protease Inhibitors pharmacology
- Abstract
A 384-well microtitre plate fluorescence cleavage assay was developed to identify inhibitors of the cysteine protease falcipain-2, an important antimalarial drug target. Bioassay-guided isolation of a MeOH extract from a myxobacterium Chitinophaga sp. Y23 isolated from soil collected in Singapore, led to the identification of a new acyltetrapeptide, falcitidin (1), which displayed an IC50 value of 6 μM against falcipain-2. The planar structure of 1 was secured by NMR and MS/MS analysis. Attempts to isolate further material for biological testing were hampered by inconsistent production and by a low yield (<100 μg l(-1)). The absolute configuration of 1 was determined by Marfey's analysis and the structure was confirmed through total synthesis as isovaleric acid-D-His-L-Ile-L-Val-L-Pro-NH2. Falcitidin (1) is the first member of a new class of falcipain-2 inhibitors and, unlike other peptide-based inhibitors, does not contain reactive groups that irreversibly bind to active cysteine sites.
- Published
- 2013
- Full Text
- View/download PDF